If you were a cancer patient, where would you rather be — the United States or Europe?

Natalie Grover

Reporter

LONDON — Frustrated by the lack of legislation implemented to lower soaring drug prices in the United States — a key issue that has elicited outrage …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

If you were a cancer patient, where would you rather be — the United States or Europe?

Natalie Grover

Reporter

Sign up to read this article for free.

CEO of UnitedHealth insurance unit shot and killed in New York

Lilly beats Novo in bellwether head-to-head weight loss study

As 23andMe struggles, another genetic testing company bets on drug discovery

GSK makes another ADC deal, this time with BioNTech's partner DualityBio

Lilly drops body mass ranges from FDA label for weight loss drug

On heels of MariTide data, Danish obesity biotech discloses €80M Series A

If you were a can­cer pa­tient, where would you rather be — the Unit­ed States or Eu­rope?

Natalie Grover

Reporter

Sign up to read this article for free.

more like this

CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

GSK makes an­oth­er ADC deal, this time with BioN­Tech's part­ner Du­al­i­ty­Bio

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

On heels of Mar­i­Tide da­ta, Dan­ish obe­si­ty biotech dis­clos­es €80M Se­ries A

If you were a cancer patient, where would you rather be — the United States or Europe?

CEO of UnitedHealth insurance unit shot and killed in New York

Lilly beats Novo in bellwether head-to-head weight loss study

As 23andMe struggles, another genetic testing company bets on drug discovery

GSK makes another ADC deal, this time with BioNTech's partner DualityBio

Lilly drops body mass ranges from FDA label for weight loss drug

On heels of MariTide data, Danish obesity biotech discloses €80M Series A